Inventor · disambiguated record
Philip R. Kym
Also filed as: KYM PHILIP R
59 granted patents·29 pending applications·463 citations·filing 1999–2024
98Inventor score
Top patents by PatentIndex Score
88 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0394US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0494US6506766B1Glucocortiocoid-selective antinflammatory agentsABBOTT LAB·Filed 2000·Granted Jan 14, 2003·74 cites·35 claims
- 0592US7119205B2Thienopyridones as AMPK activators for the treatment of diabetes and obesityABBOTT LAB·Filed 2004·Granted Oct 10, 2006·47 cites·14 claims
- 0692US6989392B22-Aminoquinolines as melanin concentrating hormone receptor antagonistsABBOTT LAB·Filed 2003·Granted Jan 24, 2006·39 cites·14 claims
- 0791US10730895B2Carbidopa prodrugABBVIE INC·Filed 2018·Granted Aug 4, 2020·2 cites·1 claims
- 0891US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0991US6329534B1Glucocorticoid receptor antagonists for treatment of diabetesABBOTT LAB·Filed 2000·Granted Dec 11, 2001·40 cites·24 claims
- 1090US6436986B1Glucocorticoid receptor antagonists for treatment of diabetesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·39 cites·9 claims
- 1186US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 1286US9446059B2Carbidopa and L-dopa prodrugs and methods of useABBVIE INC·Filed 2015·Granted Sep 20, 2016·5 cites·24 claims
- 1385US11091507B2Methods of treating Parkinson's diseaseABBVIE INC·Filed 2020·Granted Aug 17, 2021·1 cites·17 claims
- 1485US7998993B2TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·8 cites·15 claims
- 1584US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 1684US10174061B2Carbidopa and L-dopa prodrugs and methods of useABBVIE INC·Filed 2017·Granted Jan 8, 2019·3 cites·4 claims
- 1784US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 1883US10954202B2Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2020·Granted Mar 23, 2021·1 cites·4 claims
- 1982US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 2082US6818772B2Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Nov 16, 2004·17 cites·35 claims
- 2181US9567322B2Substituted tetrahydropyrans and method of useABBVIE S Á R L·Filed 2015·Granted Feb 14, 2017·4 cites·98 claims
- 2281US7998982B2Amide derivatives as TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·4 cites·6 claims
- 2380US2023106081A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2022·Application pending·0 cites
- 2479US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 2579US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 2678US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 2776US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 2875US8242139B2Inhibitors of diacylglycerol O-acyltransferase type 1 enzymeJUDD ANDREW S·Filed 2008·Granted Aug 14, 2012·3 cites·14 claims
- 2975US2022153765A1Methods of treating parkinson's diseaseABBVIE INC·Filed 2021·Application pending·0 cites
- 3073US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 3173US8604053B2TRPV1 antagonistsGOMTSYAN ARTHUR R·Filed 2009·Granted Dec 10, 2013·2 cites·32 claims
- 3273US7071182B2Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptorABBOTT LAB·Filed 2004·Granted Jul 4, 2006·6 cites·19 claims
- 3372US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 3471US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 3571US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 3671US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 3771US6921821B2Antagonists of melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Jul 26, 2005·7 cites·23 claims
- 3869US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 3969US8772499B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·45 claims
- 4069US8772500B2TRPV3 modulatorsABBVIE INC·Filed 2012·Granted Jul 8, 2014·1 cites·33 claims
- 4169US7521439B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2006·Granted Apr 21, 2009·1 cites·12 claims
- 4269US6645968B2Potassium channel openersABBOTT LAB·Filed 2001·Granted Nov 11, 2003·5 cites·78 claims
- 4368US6593335B1Potassium channel openersABBOTT LAB·Filed 1999·Granted Jul 15, 2003·28 cites·54 claims
- 4463US6951942B2Glucocorticoid-selective anti-inflammatory agentsLIGAND PHARM INC·Filed 2002·Granted Oct 4, 2005·1 cites·29 claims
- 4563US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 4662US2024024338A1Carbidopa and l-dopa prodrugs and methods of useABBVIE INC·Filed 2023·Application pending·0 cites
- 4762US2025122160A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2024·Application pending·0 cites
- 4860US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 4959US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 5058US8076344B2Inhibitors of diacylglycerol O-acyltransferase type 1 enzymeLIU GANG·Filed 2008·Granted Dec 13, 2011·0 cites·13 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philip R. Kym files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →